HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.

Abstract
Diclofenac sodium (Dc), an anti-inflammatory agent, has remarkable inhibitory action both against drug-sensitive and drug-resistant clinical isolates of various Gram-positive and Gram-negative bacteria. The aim of this study was to determine the ability of Dc to protect mice from a virulent Salmonella infection. Dc injected at 1.5 microg/g and 3.0 microg/g mouse body weight significantly protected animals from the lethality of Salmonella infection. As was the case for the in vitro interaction, Dc in combination with streptomycin was even more effective. The non-antibiotic drug Dc has potential for the management of problematic antibiotic-resistant bacterial infections.
AuthorsNoton Kumar Dutta, Subramanian Annadurai, Kaushiki Mazumdar, Sujata G Dastidar, Jette E Kristiansen, Joseph Molnar, Marta Martins, Leonard Amaral
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 30 Issue 3 Pg. 242-9 (Sep 2007) ISSN: 0924-8579 [Print] Netherlands
PMID17644318 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antipsychotic Agents
  • Culture Media
  • DNA, Bacterial
  • Diclofenac
  • Trifluoperazine
  • Streptomycin
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use, toxicity)
  • Antipsychotic Agents (pharmacology)
  • Bacterial Infections (drug therapy, microbiology)
  • Colony Count, Microbial
  • Culture Media
  • DNA, Bacterial (genetics, isolation & purification)
  • Diclofenac (therapeutic use, toxicity)
  • Drug Resistance, Bacterial
  • Drug Synergism
  • Escherichia coli (drug effects)
  • Escherichia coli Infections (drug therapy, microbiology)
  • Male
  • Mice
  • Microbial Sensitivity Tests
  • Plasmids (genetics)
  • Salmonella enterica (drug effects)
  • Staphylococcal Infections (drug therapy, microbiology)
  • Staphylococcus aureus (drug effects)
  • Streptomycin (pharmacology)
  • Trifluoperazine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: